FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die nicht zum Universitätsklinikum Erlangen gehören
Institut für Experimentelle und Klinische Pharmakologie und Toxikologie
Overview
Publications
(154)
Research Grants
(5)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
N1-Methylnicotinamide as Biomarker for MATE-Mediated Renal Drug–Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and Probenecid (2023)
Müller F, Hohl K, Keller S, Schmidt-Gerets S, Deutsch B, Schuler-Metz A, Fromm M, et al.
Journal article
Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine Data (2023)
Andrikyan W, Jung-Poppe L, Altenbuchner A, Nicolaus HF, Pfistermeister B, Dormann H, Fromm M, Maas R
Journal article, Original article
Cancer-Type Organic Anion Transporting Polypeptide 1B3 Is Localized in Lysosomes and Mediates Resistance against Kinase Inhibitors (2022)
Haberkorn B, Oswald S, Kehl N, Geßner A, Taudte V, Dobert J, Zunke F, et al.
Journal article
Cell-Specific Transport and Thyroid Hormone Receptor Isoform Selectivity Account for Hepatocyte-Targeted Thyromimetic Action of MGL-3196 (2022)
Hönes GS, Sivakumar RG, Hoppe C, König J, Führer D, Moeller LC
Journal article
Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial (2022)
Dürr P, Meier F, Schlichtig K, Schramm A, Schötz L, Fromm M, Dörje F
Journal article
Psychopharmakologische Behandlung von Menschen mit schwerer Demenz (2022)
Diehl K, Kratzer A, Donath C, Maas R, Fromm M, Kornhuber J, Grässel E
Journal article
POLAR-POLypharmacy, drug interActions and Risks-how can data from inpatient care support their assessment? (2022)
Scherag A, Andrikyan W, Dreischulte T, Dürr P, Fromm M, Gewehr J, Jaehde U, et al.
Journal article
Propionate induced bacterial-derived histamine promotes resolution of synovial inflammation (2022)
Dürholz K, Lucas S, Schmid E, Schaelter F, Frech M, Azizov V, Hofmann J, et al.
Conference contribution
Drug Therapy Safety with new oral Antitumor Agents for the Therapy of Prostate and Renal Cell Carcinoma: Findings from the AMBORA Study (2022)
Cuba L, Schlichtig K, Dürr P, Bellut L, Meidenbauer N, Kunath F, Goebell P, et al.
Conference contribution
AMBORA Study/AMTS Competence and Advice Center for oral Tumor Therapy (2022)
Schlichtig K
Conference contribution
‹
1
2
3
4
5
6
...
16
›